Anixa Biosciences(ANIX) - 2025 FY - Earnings Call Transcript

Anixa Biosciences (ANIX) FY 2025 Conference May 20, 2025 11:00 AM ET Speaker0 Alright. For this session, we'll have a presentation, by Anixa Biosciences. Anixa is a clinical stage immuno oncology company with a pipeline of candidates targeting breast cancer and ovarian cancer. Presenting for the company is Mr. Mike Catalani, President, Chief Operating Officer and Chief Financial Officer of of Adnexa. Mike? Speaker1 Thanks, Yi. Thanks, everybody, for being here. And, for those of you listening, webcast now o ...